ALK and non-small cell lung carcinoma: Furthermore, the analysis of EML4-ALK mutation variants revealed that variant 3 may be the predominant variant among Chinese NSCLC patients with more than half of the EML4-ALK translocations exhibiting fusions between exon 6 of EML4 and exon 20 of ALK.